Human dystrophin expressing chimeric ( DEC ) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human dystrophin expressing chimeric (
DEC
) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy
Authors
Keywords
-
Journal
Stem Cells Translational Medicine
Volume 10, Issue 10, Pages 1406-1418
Publisher
Wiley
Online
2021-07-22
DOI
10.1002/sctm.21-0054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy
- (2021) Rebecca J. Willcocks et al. JAMA Network Open
- Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models
- (2020) Lu Yu et al. Science Advances
- Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or Chemotherapy
- (2020) Michaela Döring et al. STEM CELLS AND DEVELOPMENT
- Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy
- (2020) Jerry R. Mendell et al. JAMA Neurology
- Stem cell therapy for muscular dystrophies
- (2020) Stefano Biressi et al. JOURNAL OF CLINICAL INVESTIGATION
- Transition from Childhood to Adulthood in Patients with Duchenne Muscular Dystrophy
- (2020) Eliza Wasilewska et al. Medicina-Lithuania
- Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia
- (2019) Sarah Marktel et al. NATURE MEDICINE
- Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial
- (2019) Michael Taylor et al. NEUROLOGY
- In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials
- (2019) Nils Tappenbeck et al. CYTOTHERAPY
- Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy
- (2019) Lindsay N. Alfano et al. MEDICINE
- Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta‐analysis of disease progression rates in recent multicenter clinical trials
- (2019) Craig M. McDonald et al. MUSCLE & NERVE
- Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients
- (2018) Dongsheng Duan HUMAN GENE THERAPY
- Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells
- (2018) Tatsunori Goto et al. MEDICINE
- Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements
- (2018) Michael Kosicki et al. NATURE BIOTECHNOLOGY
- Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy
- (2018) M. Siemionow et al. Stem Cell Reviews and Reports
- Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy
- (2018) Maria Siemionow et al. Stem Cell Reviews and Reports
- Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy
- (2018) M. Siemionow et al. Stem Cell Reviews and Reports
- Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy
- (2018) Maria Siemionow et al. Stem Cell Reviews and Reports
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study
- (2018) Francesca Bonifazi et al. BONE MARROW TRANSPLANTATION
- Ten Years of 2D Longitudinal Strain for Early Myocardial Dysfunction Detection: A Clinical Overview
- (2018) Concetta Zito et al. Biomed Research International
- Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy
- (2017) Akinori Nakamura JOURNAL OF HUMAN GENETICS
- Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy
- (2017) Peter Gee et al. Stem Cells International
- Cardiac Characterization ofmdxMice Using High-Resolution Doppler Echocardiography
- (2017) Abdallah Fayssoil et al. JOURNAL OF ULTRASOUND IN MEDICINE
- Evolving paradigms in clinical pharmacology and therapeutics for the treatment of Duchenne muscular dystrophy
- (2016) J Huard et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy
- (2016) Giulio Cossu et al. EMBO Molecular Medicine
- Why are some patients with Duchenne muscular dystrophy dying young: An analysis of causes of death in North East England
- (2016) H.J.A. Van Ruiten et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- The reversed paradigm of chimerism induction: Donor conditioning with recipient-derived bone marrow cells as a novel approach for tolerance induction in vascularized composite allotransplantation
- (2016) Maria Siemionow et al. MICROSURGERY
- Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs
- (2016) Clementina Sitzia et al. MOLECULAR THERAPY
- Confirmation of donor-derived dystrophin in a duchenne muscular dystrophy patient allotransplanted with normal myoblasts
- (2016) Daniel Skuk et al. MUSCLE & NERVE
- Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure
- (2016) M. V. Pelatti et al. Stem Cell Reviews and Reports
- Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal Muscle
- (2016) Lindsey A. Muir et al. STEM CELLS AND DEVELOPMENT
- Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy
- (2016) Jinhong Meng et al. Scientific Reports
- Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure
- (2016) M. V. Pelatti et al. Stem Cell Reviews and Reports
- Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
- (2016) Nathalie M. Goemans et al. PLoS One
- Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model
- (2015) Mikael Hivelin et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients
- (2015) Daniel Skuk et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice
- (2015) Yu Zhang et al. HUMAN MOLECULAR GENETICS
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- Biochemical and Functional Comparisons ofmdxandSgcg−/−Muscular Dystrophy Mouse Models
- (2015) Nathan W. Roberts et al. Biomed Research International
- Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
- (2015) Hongmei Lisa Li et al. Stem Cell Reports
- Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD
- (2014) Maddalena Noviello et al. MOLECULAR THERAPY
- Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA
- (2014) C. Long et al. SCIENCE
- Application of 3-D Echocardiography and Gated Micro-Computed Tomography to Assess Cardiomyopathy in a Mouse Model of Duchenne Muscular Dystrophy
- (2014) Andrew B. Bondoc et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- Myogenic Differentiation of Muscular Dystrophy-Specific Induced Pluripotent Stem Cells for Use in Drug Discovery
- (2014) Ramzey Abujarour et al. Stem Cells Translational Medicine
- Advancements in stem cells treatment of skeletal muscle wasting
- (2014) Mirella Meregalli et al. Frontiers in Physiology
- Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study
- (2013) Hyunah Lee et al. Journal of Translational Medicine
- Application of Cell-Based Therapies in Facial Transplantation
- (2012) Maria Siemionow et al. ANNALS OF PLASTIC SURGERY
- Stem cell therapies for muscle disorders
- (2012) Francesco S. Tedesco et al. CURRENT OPINION IN NEUROLOGY
- Myoblasts Derived From Normal hESCs and Dystrophic hiPSCs Efficiently Fuse With Existing Muscle Fibers Following Transplantation
- (2012) Sébastien Goudenege et al. MOLECULAR THERAPY
- Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy
- (2012) Gunnar M. Buyse et al. PEDIATRIC PULMONOLOGY
- Injection of Vessel-Derived Stem Cells Prevents Dilated Cardiomyopathy and Promotes Angiogenesis and Endogenous Cardiac Stem Cell Proliferation inmdx/utrn−/−but Not AgedmdxMouse Models for Duchenne Muscular Dystrophy
- (2012) Ju Lan Chun et al. Stem Cells Translational Medicine
- The Dystrophin-Glycoprotein Complex in the Prevention of Muscle Damage
- (2011) Jessica D. Gumerson et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Long-term Engraftment of Multipotent Mesenchymal Stromal Cells That Differentiate to Form Myogenic Cells in Dogs With Duchenne Muscular Dystrophy
- (2011) Yuko Nitahara-Kasahara et al. MOLECULAR THERAPY
- Detection of Progressive Cardiac Dysfunction by Serial Evaluation of Circumferential Strain in Patients With Duchenne Muscular Dystrophy
- (2010) Sean C. Hagenbuch et al. AMERICAN JOURNAL OF CARDIOLOGY
- Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy
- (2010) Vinod Malik et al. ANNALS OF NEUROLOGY
- Stem cells to treat muscular dystrophies – Where are we?
- (2010) Jinhong Meng et al. NEUROMUSCULAR DISORDERS
- Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy
- (2010) Beniamino Palmieri et al. PEDIATRIC TRANSPLANTATION
- Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers†
- (2009) Natee Jearawiriyapaisarn et al. CARDIOVASCULAR RESEARCH
- Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy
- (2009) Ralf Bauer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Near-total human face transplantation for a severely disfigured patient in the USA
- (2009) Maria Siemionow et al. LANCET
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- First U.S. Near-Total Human Face Transplantation: A Paradigm Shift for Massive Complex Injuries
- (2009) Maria Z. Siemionow et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy
- (2009) Chad D. Markert et al. PM&R
- Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study
- (2008) Francesco Frassoni et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started